IP Library Patent Application 15463846
Patent Application
App. No. 15/463,846

METHODS AND COMPOSITIONS FOR MULTIPLE DISPLACEMENT AMPLIFICATION OF NUCLEIC ACIDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/463,846
Abstract

Disclosed are methods for multiple displacement amplification of a nucleic acid sequence in a sample. The nucleic acid is contacted with a reaction mixture that includes a set of oligonucleotide primers and a plurality of polymerase enzymes. The reaction mixture is subjected to conditions under which the nucleic acid sequence is amplified to produce an amplification product in a multiple displacement amplification reaction. Also disclosed are kits containing a set of oligonucleotide primers with random sequences having lengths of 6 to 8 nucleobases. At least some of the individual members of the primers have one or more ribose modifications that stabilize or lock the ribose ring in a 3′-endo conformation. At least some of the primers have one or more universal nucleobases.

Claims (21)

1 . A method for multiple displacement amplification of a nucleic acid sequence in a sample comprising the steps of:

contacting said nucleic acid with a reaction mixture, wherein said reaction mixture includes a set of oligonucleotide primers and a plurality of polymerase enzymes; and

subjecting said reaction mixture to conditions under which said nucleic acid sequence is amplified to produce an amplified product in a multiple displacement reaction.

2 . The method of claim 1 wherein said sample is a forensic sample comprising human DNA.

3 . The method of claim 1 wherein said plurality of polymerase enzymes have 5′→3′ DNA polymerase activity, 3′→5′ exonuclease activity, and 5′→3′ excision repair activity.

4 . The method of claim 1 wherein members of said set of oligonucleotide primers have random sequences.

5 . The method of claim 4 wherein said oligonucleotide primers have lengths of 6, 7 or 8 nucleotide residues.

6 . The method of claim 4 wherein said oligonucleotide primers include at least one universal nucleobase.

7 . The method of claim 6 wherein said universal nucleobase is inosine.

8 . The method of claim 6 wherein said universal nucleobase is located at the 3′-terminal end of said oligonucleotide primers.

9 . The method of claim 1 wherein said set of oligonucleotide primers includes primers having one or more modifications of the ribose ring that favor a 3′-endo conformation of said ribose ring or lock said ribose ring in said 3′-endo conformation.

10 . The method of claim 9 wherein said modifications comprise a 2′ to 4′ ribose bridge.

11 . The method of claim 10 wherein said modifications are located at the 2nd and 5th positions of said primers.

12 . The method of claim 1 wherein said one or more enzymes include phi29 polymerase and pol I polymerase.

13 . The method of claim 1 wherein said one or more enzymes further includes pyrophosphatase.

14 . The method of claim 1 including the proviso that bovine serum albumin is not included in said reaction mixture.

15 . The method of claim 1 wherein said reaction mixture comprises betaine and trehalose.

16 . The method of claim 1 wherein said conditions comprise thermal cycling of said reaction mixture.

17 . The method of claim 1 wherein said multiple displacement amplification results in whole genome amplification.

18 . The method of claim 1 wherein said multiple displacement amplification reaction produces said amplification product at a constant ratio relative to production of other amplification products of other nucleic acids present in said sample.

19 . The method of claim 1 wherein the total quantity of said nucleic acid sequence is between about 2 picograms to about 1000 picograms.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2018
From: ESHOO, MARK W; DUNCAN, DAVID D
To: IBIS BIOSCIENCES, INC.
Reel/Frame 045734/0434 →